Federal Register / Vol. 88, No. 185 / Tuesday, September 26, 2023 / Notices 66001 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in the BHC Act 

(12 U.S.C. 1842(c)). If the proposal also 

involves the acquisition of a nonbanking 

company, the review also includes 

whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843), and interested persons 

may express their views in writing on 

the standards enumerated in section 4. 

Unless otherwise noted, nonbanking 

activities will be conducted throughout 

the United States. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than October 26, 2023. 

A. Federal Reserve Bank of Richmond 

(Brent B. Hassell, Assistant Vice 

President) 701 East Byrd Street, 

Richmond, Virginia 23219. Comments 

can also be sent electronically to 

Comments.applications@rich.frb.org: 

1. Southern Bancshares (N.C.), Inc., 

Mount Olive, North Carolina; to acquire 

up to 19.9 percent of the voting shares 

of Old Point Financial Corporation, 

Hampton, Virginia, and thereby 

indirectly acquire voting shares of The 

Old Point National Bank of Phoebus, 

Hampton, Virginia, and Old Point Trust 

& Financial Services, N.A., Newport 

News, Virginia. In addition, Southern 

Bancshares (N.C.), Inc., through the 

acquisition of Old Point Trust & 

Financial Services, N.A., will engage in 

providing trust company functions and 

securities brokerage services pursuant to 

sections 225.28(b)(5) and (b)(7)(i) of the 

Board’s Regulation Y, respectively. This 

notice replaces and supersedes FR Doc 

2023–62785 published on 09–13–2023. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2023–20935 Filed 9–25–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–23–0840; Docket No. CDC–2023– 

0078] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled ‘‘Formative 

Research and Tool Development’’. This 

information collection request is 

designed to allow CDC’s National Center 

for HIV, Viral Hepatitis, STD, and TB 

Prevention (NCHHSTP) to conduct 

formative research information 

collection activities used to inform 

many aspects of surveillance, 

communications, health promotion, and 

research project development for 

NCHHSTP’s four priority diseases (HIV/ 

AIDS), sexually transmitted diseases/ 

infections (STD/STI), viral hepatitis, 

tuberculosis elimination (TB), and 

school and adolescent health (DASH). 

DATES: CDC must receive written 

comments on or before November 27, 

2023. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2023– 

0078 by any of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7118; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Formative Research and Tool 

Development (OMB Control No. 0920– 


lotter on DSK11XQN23PROD with NOTICES1
66002 Federal Register / Vol. 88, No. 185 / Tuesday, September 26, 2023 / Notices 

0840, Exp. 7/31/2024)—Extension— 

National Center for HIV, Viral Hepatitis, 

STD, TB Prevention (NCHHSTP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

The Centers for Disease Control and 

Prevention (CDC), National Center for 

HIV, Viral Hepatitis, STD, and TB 

Prevention (NCHHSTP) requests 

approval for an Extension and a threeyear approval for the previously 

approved Generic Clearance, 

‘‘Formative Research and Tool 

Development’’. This information 

collection request is designed to allow 

NCHHSTP to conduct formative 

research information collection 

activities used to inform many aspects 

of surveillance, communications, health 

promotion, and research project 

development for NCHHSTP’s four 

priority diseases (HIV/AIDS, sexually 

transmitted diseases/infections (STD/ 

STI), viral hepatitis, tuberculosis 

elimination and the Division of School 

and Adolescent Heath (DASH)). 

Formative research is the basis for 

developing effective strategies including 

communication channels, for 

influencing behavior change. It helps 

researchers identify and understand the 

characteristics—interests, behaviors and 

needs—of target populations that 

influence their decisions and actions. 

Formative research is integral in 

developing programs as well as 

improving existing and ongoing 

programs. Formative research also looks 

at the community in which a public 

health intervention is being, or will be 

implemented, and helps the project staff 

understand the interests, attributes and 

needs of different populations and 

persons in that community. Formative 

research is research that occurs before a 

program is designed and implemented, 

or while a program is being conducted. 

NCHHSTP formative research is 

necessary for developing new programs 

or adapting programs that deal with the 

complexity of behaviors, social context, 

cultural identities, and health care that 

underlie the epidemiology of HIV/AIDS, 

viral hepatitis, STDs, and TB in the U.S, 

as well as for school and adolescent 

health. CDC conducts formative 

research to develop public-sensitive 

communication messages and userfriendly tools prior to developing or 

recommending interventions, or care. 

Sometimes these studies are entirely 

behavioral but most often they are 

cycles of interviews and focus groups 

designed to inform the development of 

a product. 

Products from these formative 

research studies will be used for 

prevention of HIV/AIDS, Sexually 

Transmitted Infections (STI), viral 

Hepatitis, and Tuberculosis. Findings 

from these studies may also be 

presented as evidence to diseasespecific National Advisory Committees, 

to support revisions to recommended 

prevention and intervention methods, as 

well as to develop new 

recommendations. Much of CDC’s 

health communication takes place 

within campaigns that have lengthy 

planning periods—timeframes that 

accommodate the standard federal 

process for approving data collections. 

Short-term qualitative interviewing and 

cognitive research techniques have 

previously proven invaluable in the 

development of scientifically valid and 

population-appropriate methods, 

interventions, and instruments. 

This request includes studies 

investigating the utility and 

acceptability of proposed sampling and 

recruitment methods, intervention 

contents and delivery, questionnaire 

domains, individual questions, and 

interactions with project staff or 

electronic data collection equipment. 

These activities will also provide 

information about how respondents 

answer questions and ways in which 

question response bias and error can be 

reduced. This request also includes 

collection of information from public 

health programs to assess needs related 

to initiation of a new program activity 

or expansion or changes in scope or 

implementation of existing program 

activities to adapt them to current 

needs. The information collected will be 

used to advise programs and provide 

capacity-building assistance tailored to 

identified needs. 

Overall, these development activities 

are intended to provide information that 

will increase the success of the 

surveillance or research projects 

through increasing response rates and 

decreasing response error, thereby 

decreasing future data collection burden 

to the public. The studies that will be 

covered under this request will include 

one or more of the following 

investigational modalities: (1) structured 

and qualitative interviewing for 

surveillance, research, interventions and 

material development; (2) cognitive 

interviewing for development of specific 

data collection instruments; (3) 

methodological research; (4) usability 

testing of technology-based instruments 

and materials; (5) field testing of new 

methodologies and materials; (6) 

investigation of mental models for 

health decision-making, to inform 

health communication messages; and (7) 

organizational needs assessments to 

support development of capacity. 

Respondents who will participate in 

individual and group interviews 

(qualitative, cognitive, and computer 

assisted development activities) are 

selected purposively from those who 

respond to recruitment advertisements. 

In addition to utilizing advertisements 

for recruitment, respondents who will 

participate in research on survey 

methods may be selected purposively or 

systematically from within an ongoing 

surveillance or research project. 

CDC requests OMB approval for an 

estimated 6,657 annual burden hours. 

Participation of respondents is 

voluntary, and there is no cost to 

participants other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average hours 

per response 

Total response 

burden 

(hours) 

General public ................................... Screener ........................................... 56,840 1 10/60 9,473 

Health care providers ....................... Screener ........................................... 24,360 1 10/60 4,060 

General public ................................... Consent Forms ................................. 28,420 1 5/60 2,368 

Health care providers ....................... Consent Forms ................................. 12,180 1 5/60 1,015 

General public ................................... Individual Interview ........................... 4,620 1 1 4,620 

Health care providers ....................... Individual Interview ........................... 1,980 1 1 1,980 

General public ................................... Focus Group Interview ..................... 2,800 1 2 5,600 

Health care providers ....................... Focus Group Interview ..................... 1,200 1 2 2,400 

General public ................................... Survey of Individual .......................... 21,000 1 30/60 10,500 

Health care providers ....................... Survey of Individual .......................... 9,000 1 30/60 4,500 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 185 / Tuesday, September 26, 2023 / Notices 66003 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average hours 

per response 

Total response 

burden 

(hours) 

Total ........................................... ........................................................... ........................ ........................ ........................ 46,516 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2023–20761 Filed 9–25–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–23–1305] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Chronic Q 

Fever in the United States: Enhanced 

Clinical Surveillance’’ to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on June 27, 

2023 to obtain comments from the 

public and affected agencies. CDC 

received no comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Chronic Q Fever in the United States: 

Enhanced Clinical Surveillance (OMB 

Control No. 0920–1305, Exp. 9/30/ 

2023)—Revision—National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

Q fever is a worldwide zoonosis 

caused by Coxiella burnetii with acute 

and chronic disease presentations. 

Chronic Q fever can manifest months to 

years after the primary infection and is 

rare, occurring in <5% of persons with 

an acute infection. Chronic Q fever can 

take on several clinical forms, including 

endocarditis, chronic hepatitis, chronic 

vascular infections, osteomyelitis, and 

osteoarthritis. In the United States, Q 

fever cases are reported via the National 

Notifiable Disease Surveillance System; 

however, limited information is 

collected on the various clinical 

manifestations of chronic Q fever or 

patients pre-existing risk factors. Data 

on outcomes other than death or 

hospitalizations are not collected by the 

current surveillance. Because of this 

lack of data, the true burden and 

proportion of cases exhibiting 

endocarditis and other forms of chronic 

Q fever in the United States is 

unknown. We plan to establish an 

enhanced medical surveillance for 

chronic Q fever by working with 

consulting clinicians to gather 

additional and more specific clinical 

data not otherwise collected during the 

course of routine public health 

surveillance for chronic Q fever. This 

information will allow for better 

characterization of the clinical 

presentation and risk factors of chronic 

Q fever in the United States. The results 

will help characterize an underrecognized disease and provide valuable 

data to educate physicians on 

identifying and diagnosing these cases. 

Recently, there has been an increased 

volume of clinical consultation requests. 

To reflect this, we are proposing an 

increase in the number of respondents 

to 50 each year. Additionally, the 

clinical course for these patients is often 

complex, and clinical relapse or 

prolonged infection has been reported. 

To capture these important clinical 

details, we propose increasing the 

number of total instruments to two, with 

a follow-up survey that will take five 

minutes each at six, 12, 18, and 24 

months from the date of the initial 

consult. 

CDC requests OMB approval for an 

estimated 34 annual burden hours. 

There is no cost to respondents other 

than their time to participate. 


lotter on DSK11XQN23PROD with NOTICES1